J.C. Romijn
- Co-authors
- Jan TrapmanJ.A.G.M. van der KorputPeter RiegmanCarl F. VerkoelenG.J. van SteenbruggeFritz H. SchroederFritz H. SchröderR.J. Vlietstra
- Topics
- Renal cell carcinoma treatment (5 papers)Cancer Genomics and Diagnostics (5 papers)Prostate Cancer Treatment and Research (5 papers)
- Partner nations
- NetherlandsIsraelUnited States
In The Last Decade
J.C. Romijn
32 papers receiving 973 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 518
- Pulmonary and Respiratory Medicine 401
- Oncology 183
- Genetics 121
- Cancer Research 107
Countries citing papers authored by J.C. Romijn
This map shows the geographic impact of J.C. Romijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Romijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Romijn more than expected).
Fields of papers citing papers by J.C. Romijn
This network shows the impact of papers produced by J.C. Romijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Romijn. The network helps show where J.C. Romijn may publish in the future.
Co-authorship network of co-authors of J.C. Romijn
This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Romijn. A scholar is included among the top collaborators of J.C. Romijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Romijn. J.C. Romijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | 91 | |
| 4 | 18 | |
| 5 | Development of seven new human prostate tumor xenograft models and their histopathological characterization. | 133 |
| 6 | 18 | |
| 7 | 13 | |
| 8 | 9 | |
| 9 | Negative control of epithelial cell proliferation by prostatic stroma. | 8 |
| 10 | 64 | |
| 11 | 128 | |
| 12 | 137 | |
| 13 | 87 | |
| 14 | In vivo and in vitro chemotherapy sensitivity testing for human kidney tumor lines: a comparative study. | 1 |
| 15 | 0 | |
| 16 | 4 | |
| 17 | 13 | |
| 18 | 33 | |
| 19 | 11 | |
| 20 | 54 |
About J.C. Romijn
J.C. Romijn is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 33 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (5 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (401 citations), Genetics (103 citations) and Molecular Biology (518 citations). J.C. Romijn has collaborated with scholars based in Netherlands, Israel and United States. Frequent co-authors include Jan Trapman, J.A.G.M. van der Korput, Peter Riegman, Carl F. Verkoelen, G.J. van Steenbrugge, Fritz H. Schroeder, Fritz H. Schröder, R.J. Vlietstra, Paul Klaassen and J. Amesz. Their work appears in journals such as Biochemical and Biophysical Research Communications, FEBS Letters and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.